Co-targeting of IGF-1R (Dalotuzumab) and EGFR (Erlotinib[80], Cetuximab [50]) however did not improve outcomes
Total Vial Content: 10mg
However, the performance on this test tends to be dichotomous, and there is limited evidence that olfactory function continues to decline as the disease progresses, possibly because olfactory dysfunction appears at very early stages and rapidly approaches a floor effect, leaving little room to capture further decline
Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME
Since this ingredient is an ester of a C18 fatty acid, it may not be fungal acne safe
Directions: Take one half teaspoon (1 gram) daily, or as directed by a physician